24 related articles for article (PubMed ID: 7603615)
1. Changes in vasoactive intestinal peptide and arginine vasopressin expression in the suprachiasmatic nucleus of the rat brain following footshock stress.
Handa RJ; Zoeller RT; McGivern RF
Neurosci Lett; 2007 Sep; 425(2):99-104. PubMed ID: 17826907
[TBL] [Abstract][Full Text] [Related]
2. Aging alters the rhythmic expression of vasoactive intestinal polypeptide mRNA but not arginine vasopressin mRNA in the suprachiasmatic nuclei of female rats.
Krajnak K; Kashon ML; Rosewell KL; Wise PM
J Neurosci; 1998 Jun; 18(12):4767-74. PubMed ID: 9614250
[TBL] [Abstract][Full Text] [Related]
3. Neonatal exposure to monosodium glutamate induces morphological alterations in suprachiasmatic nucleus of adult rat.
Rojas-Castañeda JC; Vigueras-Villaseñor RM; Chávez-Saldaña M; Rojas P; Gutiérrez-Pérez O; Rojas C; Arteaga-Silva M
Int J Exp Pathol; 2016 Feb; 97(1):18-26. PubMed ID: 26799547
[TBL] [Abstract][Full Text] [Related]
4. Identification of VGF nerve growth factor inducible-producing cells in human spinal cords and expression change in patients with amyotrophic lateral sclerosis.
Noda Y; Tanaka M; Nakamura S; Ito J; Kakita A; Hara H; Shimazawa M
Int J Med Sci; 2020; 17(4):480-489. PubMed ID: 32174778
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide VGF-Derived Peptide LQEQ-19 has Neuroprotective Effects in an In Vitro Model of Amyotrophic Lateral Sclerosis.
Noda Y; Motoyama S; Nakamura S; Shimazawa M; Hara H
Neurochem Res; 2019 Apr; 44(4):897-904. PubMed ID: 30656593
[TBL] [Abstract][Full Text] [Related]
6. Endogenous peptide discovery of the rat circadian clock: a focused study of the suprachiasmatic nucleus by ultrahigh performance tandem mass spectrometry.
Lee JE; Atkins N; Hatcher NG; Zamdborg L; Gillette MU; Sweedler JV; Kelleher NL
Mol Cell Proteomics; 2010 Feb; 9(2):285-97. PubMed ID: 19955084
[TBL] [Abstract][Full Text] [Related]
7. Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor.
Levi A; Ferri GL; Watson E; Possenti R; Salton SR
Cell Mol Neurobiol; 2004 Aug; 24(4):517-33. PubMed ID: 15233376
[TBL] [Abstract][Full Text] [Related]
8. VGF: A prospective biomarker and therapeutic target for neuroendocrine and nervous system disorders.
Wang Y; Qin X; Han Y; Li B
Biomed Pharmacother; 2022 Jul; 151():113099. PubMed ID: 35594706
[TBL] [Abstract][Full Text] [Related]
9. In situ hybridization histochemistry of vghm1f mRNA in the rat suprachiasmatic nucleus: co-localization with vasopressin/neurophysin and VIP/PHI.
Okamura H; Tanaka M; Kanemasa K; Ban Y; Inouye SI; Ibata Y
Neurosci Lett; 1994 Dec; 182(2):181-4. PubMed ID: 7715806
[TBL] [Abstract][Full Text] [Related]
10. Substance P in the suprachiasmatic nucleus of the rat: an immunohistochemical and in situ hybridization study.
Mikkelsen JD; Larsen PJ
Histochemistry; 1993 Jul; 100(1):3-16. PubMed ID: 7693627
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide/peptide histidine isoleucine mRNA in the eye and suprachiasmatic nucleus of normal and monocularly enucleated rats.
Denis P; Dussaillant M; Nordmann JP; Bérod A; Saraux H; Rostène W
Graefes Arch Clin Exp Ophthalmol; 1993 Sep; 231(9):541-5. PubMed ID: 8224959
[TBL] [Abstract][Full Text] [Related]
12. Day-night variation in prepro vasoactive intestinal peptide/peptide histidine isoleucine mRNA within the rat suprachiasmatic nucleus.
Albers HE; Stopa EG; Zoeller RT; Kauer JS; King JC; Fink JS; Mobtaker H; Wolfe H
Brain Res Mol Brain Res; 1990 Jan; 7(1):85-9. PubMed ID: 2153898
[TBL] [Abstract][Full Text] [Related]
13. Localization of vasopressin-, vasoactive intestinal polypeptide-, peptide histidine isoleucine- and somatostatin-mRNA in rat suprachiasmatic nucleus.
Card JP; Fitzpatrick-McElligott S; Gozes I; Baldino F
Cell Tissue Res; 1988 May; 252(2):307-15. PubMed ID: 2898292
[TBL] [Abstract][Full Text] [Related]
14. In situ hybridization histochemistry of vgf mRNA in the rat suprachiasmatic nucleus: co-localization with vasopressin/neurophysin and VIP/PHI.
Okamura H; Tanaka M; Kanemasa K; Ban Y; Inouye ST; Ibata Y
Neurosci Lett; 1995 Apr; 189(1):181-4a. PubMed ID: 7603615
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
